Toshinori Hirai (T Hirai)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Venues

British journal of clinical pharmacology

Pharmacology research & perspectives

Basic & clinical pharmacology & toxicology

Journal of clinical pharmacy and therapeutics

Tokyo Joshi Ika Daigaku Higashi Iryo Center

Meiji Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tokyo Joshi Ika Daigaku Higashi Iryo Center Apr 01 2018

Japan

Chief Pharmacist :: Pharmacy

Tokyo Joshi Ika Daigaku Higashi Iryo Center Jun 01 2017 - Mar 31 2018

Japan

Pharmacist :: Pharmacy

Tokyo Joshi Ika Daigaku Byoin Apr 01 2009 - May 31 2017

Japan

Pharmacist :: Pharmacy

Education History

Meiji Pharmaceutical University Apr 01 2012 - Sep 30 2016

Japan

PHD

Publications

Toshinori Hirai, Yuki Kondo, Yuka Sakazaki, Ayaka Seki, Yoichi Ishitsuka, Takuya Iwamoto
Drug-drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports. Scientific reports 13 (1) (2023)
Masahiro Sakai, Toshinori Hirai, Satoshi Shitara, Takuya Iwamoto, Tsuyoshi Shiga
Comparison of creatinine-based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure. Pharmacology research & perspectives 11 (1) (2023)
Masahiro Sakai, Toshinori Hirai, Satoshi Shitara, Takuya Iwamoto, Tsuyoshi Shiga
Comparison of creatinine-based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure. Pharmacology research & perspectives 11 (1) (2023)
Yuri Shinogi, Toshinori Hirai, Miki Ishibashi, Kazuko Ino, Isao Tawara, Takuya Iwamoto
Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis. Pharmacology research & perspectives 11 (4) (2023)
Toshinori Hirai, Yoshihiko Morikawa, Ritsuki Onishi, Yusuke Nakatani, Kouhei Nishikawa, Takahiro Inoue, Takuya Iwamoto
Impact of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation. British journal of clinical pharmacology (2023)
Masahiro Sakai, Toshinori Hirai, Satoshi Shitara, Takuya Iwamoto, Tsuyoshi Shiga
Comparison of creatinine-based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure. Pharmacology research & perspectives 11 (1) (2023)
Toshinori Hirai, Yoshihiko Morikawa, Ritsuki Onishi, Yusuke Nakatani, Kouhei Nishikawa, Takahiro Inoue, Takuya Iwamoto
Impact of glycemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation. British journal of clinical pharmacology (2023)
Toshinori Hirai, Takahiko Aoyama, Yasuhiro Tsuji, Toshimasa Itoh, Yoshiaki Matsumoto, Takuya Iwamoto
Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients. British journal of clinical pharmacology (2023)
Toshinori Hirai, Kazuko Ino, Makoto Ikejiri, Isao Tawara, Takuya Iwamoto
Dual Inhibition of CYP3A4 by Voriconazole and Clarithromycin Influences Tacrolimus Pharmacokinetics: Case Series Study. European journal of drug metabolism and pharmacokinetics 47 (6) (2022)
Toshinori Hirai, Chihiro Shiraishi, Sumire Nakai, Miu Ushiro, Kazuhiko Hanada, Takuya Iwamoto
Population kinetic-pharmacodynamic analysis of serum potassium in patients receiving sulfamethoxazole/trimethoprim. Basic & clinical pharmacology & toxicology 131 (5) (2022)
Toshinori Hirai, Hidefumi Kasai, Miyoko Naganuma, Nobuhisa Hagiwara, Tsuyoshi Shiga
Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data. BMC pharmacology & toxicology 23 (1) (2022)
Toshinori Hirai, Yuri Shinogi, Makoto Ikejiri, Tomohiro Murata, Takuya Iwamoto
Evaluation of bleeding and anticoagulation markers by edoxaban and low-dose cyclosporine: A case series study. Biopharmaceutics & drug disposition 43 (5) (2022)
Toshinori Hirai, Kazuhiko Hanada, Takuya Iwamoto, Toshimasa Itoh
Involvement of the effect of renal hypoperfusion medications on vancomycin trough concentration: A secondary analysis using a retrospective observational data. Basic & clinical pharmacology & toxicology 129 (5) (2021)
Toshinori Hirai, Keiko Hosohata, Yukari Ogawa, Takuya Iwamoto
Clinical predictors of nephrotoxicity associated with teicoplanin: Meta-analysis and meta-regression. Basic & clinical pharmacology & toxicology (2021)
Toshinori Hirai, Ayako Funaki, Kumi Murakami, Kazuhiko Hanada, Toshimasa Itoh
Effects of overweight and underweight on the treatment outcomes of rheumatoid arthritis patients treated with biological drugs: A retrospective observational descriptive study. Journal of clinical pharmacy and therapeutics 45 (4) (2020)
Toshinori Hirai, Kazuhiko Hanada, Ayako Kanno, Megumi Akashi, Toshimasa Itoh
Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment. European journal of clinical pharmacology 75 (6) (2019)
Toshinori Hirai, Yukari Shuji, Megumi Takiyama, Kazuhiko Hanada, Toshimasa Itoh
Renin-angiotensin system inhibitors for countering proteinuria induced by angiogenesis inhibitors: a retrospective observational analysis. Cancer chemotherapy and pharmacology 84 (1) (2019)
Toshinori Hirai, R Yamaga, A Fujita, T Itoh
Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments. Journal of clinical pharmacy and therapeutics 43 (6) (2018)
Toshinori Hirai, Ryuichi Ogawa, Ryosuke Yamaga, Toshimasa Itoh
Impact of relative dose intensity on bone marrow suppression induced by S-1: retrospective observational study. Journal of pharmaceutical health care and sciences 4 (2018)
Toshinori Hirai, Toshimasa Itoh, Toshimi Kimura, Hirotoshi Echizen
Evaluation of a pharmacokinetic-pharmacodynamic model for hypouricaemic effects of febuxostat using datasets obtained from real-world patients. British journal of clinical pharmacology 84 (10) (2018)

Toshinori Hirai.css-eqlu8i{font-size:small;padding-left:4px;} (T Hirai)

Publication Activity (10 Years)

Top Topics

Top Venues

Toshinori Hirai (T Hirai)